10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001558370-23-018018 |
| Period End Date | 20230930 |
| Filing Date | 20231107 |
| Fiscal Year | 2024 |
| Fiscal Period | Q1 |
| XBRL Instance | tmb-20230930x10q_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
86 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Accounts receivable, allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$4.92M | USD | Point-in-time |
| Accounts receivable, allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$4.74M | USD | Point-in-time |
| Undesignated capital stock, no par (in dollars per share) |
UndesignatedCapitalStockNoParValue
|
- | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$180.57M | USD | Point-in-time |
| Undesignated capital stock, no par (in dollars per share) |
UndesignatedCapitalStockNoParValue
|
- | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$148.66M | USD | Point-in-time |
| Undesignated capital stock, shares authorized (in shares) |
UndesignatedCapitalStockSharesAuthorized
|
5.00M | shares | Point-in-time |
| Undesignated capital stock, shares authorized (in shares) |
UndesignatedCapitalStockSharesAuthorized
|
5.00M | shares | Point-in-time |
| Short-term available-for-sale investments |
ShortTermInvestments
|
$23.74M | USD | Point-in-time |
| Undesignated capital stock, shares issued (in shares) |
UndesignatedCapitalStockSharesIssued
|
0.00 | shares | Point-in-time |
| Undesignated capital stock, shares issued (in shares) |
UndesignatedCapitalStockSharesIssued
|
0.00 | shares | Point-in-time |
| Accounts receivable, less allowance for doubtful accounts of $4,920 and $4,738, respectively |
AccountsReceivableNetCurrent
|
$204.57M | USD | Point-in-time |
| Accounts receivable, less allowance for doubtful accounts of $4,920 and $4,738, respectively |
AccountsReceivableNetCurrent
|
$218.47M | USD | Point-in-time |
| Undesignated capital stock, shares outstanding (in shares) |
UndesignatedCapitalStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Inventories |
InventoryNet
|
$186.08M | USD | Point-in-time |
| Undesignated capital stock, shares outstanding (in shares) |
UndesignatedCapitalStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Inventories |
InventoryNet
|
$171.64M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$27.07M | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$52.16M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$591.48M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
400.00M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$621.48M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
400.00M | shares | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
400.00M | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$231.68M | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
158.35M | shares | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
157.64M | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$226.20M | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
158.35M | shares | Point-in-time |
| Right of use asset |
OperatingLeaseRightOfUseAsset
|
$98.33M | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
157.64M | shares | Point-in-time |
| Right of use asset |
OperatingLeaseRightOfUseAsset
|
$102.28M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$872.74M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$969.38M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$578.97M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$534.64M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$285.30M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$281.58M | USD | Point-in-time |
| Total assets |
Assets
|
$2.76B | USD | Point-in-time |
| Total assets |
Assets
|
$2.64B | USD | Point-in-time |
| Trade accounts payable |
AccountsPayableCurrent
|
$28.08M | USD | Point-in-time |
| Trade accounts payable |
AccountsPayableCurrent
|
$25.68M | USD | Point-in-time |
| Salaries, wages and related accruals |
EmployeeRelatedLiabilitiesCurrent
|
$34.89M | USD | Point-in-time |
| Salaries, wages and related accruals |
EmployeeRelatedLiabilitiesCurrent
|
$36.75M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$14.88M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$15.94M | USD | Point-in-time |
| Contract liabilities |
ContractWithCustomerLiabilityCurrent
|
$24.52M | USD | Point-in-time |
| Contract liabilities |
ContractWithCustomerLiabilityCurrent
|
$23.07M | USD | Point-in-time |
| Income taxes payable |
AccruedIncomeTaxesCurrent
|
$5.94M | USD | Point-in-time |
| Income taxes payable |
AccruedIncomeTaxesCurrent
|
$12.02M | USD | Point-in-time |
| Operating lease liabilities - current |
OperatingLeaseLiabilityCurrent
|
$12.20M | USD | Point-in-time |
| Operating lease liabilities - current |
OperatingLeaseLiabilityCurrent
|
$11.20M | USD | Point-in-time |
| Contingent consideration payable |
BusinessCombinationContingentConsiderationLiabilityCurrent
|
$3.50M | USD | Point-in-time |
| Contingent consideration payable |
BusinessCombinationContingentConsiderationLiabilityCurrent
|
$1.75M | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$1.41M | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$4.44M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$128.51M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$127.75M | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxLiabilitiesNet
|
$88.98M | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxLiabilitiesNet
|
$83.13M | USD | Point-in-time |
| Long-term debt obligations |
LongTermDebtAndCapitalLeaseObligations
|
$350.00M | USD | Point-in-time |
| Long-term debt obligations |
LongTermDebtAndCapitalLeaseObligations
|
$440.00M | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$97.33M | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$93.77M | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$9.39M | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$10.92M | USD | Point-in-time |
| Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding |
UndesignatedCapitalStockValue
|
- | USD | Point-in-time |
| Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding |
UndesignatedCapitalStockValue
|
- | USD | Point-in-time |
| Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 158,354,579 and 157,641,914 respectively |
CommonStockValue
|
$1.58M | USD | Point-in-time |
| Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 158,354,579 and 157,641,914 respectively |
CommonStockValue
|
$1.58M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$746.61M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$721.54M | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$1.31B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$1.33B | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-78.02M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-66.06M | USD | Point-in-time |
| Total Bio-Techne's shareholders' equity |
StockholdersEquity
|
$2.00B | USD | Point-in-time |
| Total Bio-Techne's shareholders' equity |
StockholdersEquity
|
$1.97B | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$1.97B | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$2.00B | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$1.70B | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$1.75B | USD | Point-in-time |
| Total liabilities and shareholders' equity |
LiabilitiesAndStockholdersEquity
|
$2.64B | USD | Point-in-time |
| Total liabilities and shareholders' equity |
LiabilitiesAndStockholdersEquity
|
$2.76B | USD | Point-in-time |
Income Statement
46 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Stock dividend stock spilt |
StockholdersEquityNoteStockSplitConversionRatio1
|
4.00 | pure | Point-in-time |
| Net sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$276.94M | USD | 1 Quarter |
| Net sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$269.65M | USD | 1 Quarter |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$90.06M | USD | 1 Quarter |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$91.74M | USD | 1 Quarter |
| Gross margin |
GrossProfit
|
$185.19M | USD | 1 Quarter |
| Gross margin |
GrossProfit
|
$179.59M | USD | 1 Quarter |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$99.38M | USD | 1 Quarter |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$105.33M | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$24.00M | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$23.90M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$123.28M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$129.33M | USD | 1 Quarter |
| Operating income |
OperatingIncomeLoss
|
$55.86M | USD | 1 Quarter |
| Operating income |
OperatingIncomeLoss
|
$56.32M | USD | 1 Quarter |
| Other income (expense) |
NonoperatingIncomeExpense
|
$-6.30M | USD | 1 Quarter |
| Other income (expense) |
NonoperatingIncomeExpense
|
$47.40M | USD | 1 Quarter |
| Earnings before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$103.72M | USD | 1 Quarter |
| Earnings before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$49.56M | USD | 1 Quarter |
| Income taxes (benefit) |
IncomeTaxExpenseBenefit
|
$13.98M | USD | 1 Quarter |
| Income taxes (benefit) |
IncomeTaxExpenseBenefit
|
$-1.44M | USD | 1 Quarter |
| Net earnings, including noncontrolling interest |
ProfitLoss
|
$89.73M | USD | 1 Quarter |
| Net earnings, including noncontrolling interest |
ProfitLoss
|
$50.99M | USD | 1 Quarter |
| Net earnings attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$179.00K | USD | 1 Quarter |
| Net earnings attributable to Bio-Techne |
NetIncomeLoss
|
$50.99M | USD | 1 Quarter |
| Net earnings attributable to Bio-Techne |
NetIncomeLoss
|
$89.56M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$-11.60M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$-21.46M | USD | 1 Quarter |
| Foreign currency translation reclassified to earnings with Eminence deconsolidation |
OtherComprehensiveIncomeLossReleaseOfForeignCurrencyTransactionAndTranslationFromSalePortionAttributableToParent
|
$119.00K | USD | 1 Quarter |
| Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8 |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
|
$4.70M | USD | 1 Quarter |
| Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8 |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
|
$-350.00K | USD | 1 Quarter |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-11.95M | USD | 1 Quarter |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-16.64M | USD | 1 Quarter |
| Other comprehensive income (loss) attributable to noncontrolling interest |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
|
$-33.00K | USD | 1 Quarter |
| Other comprehensive income (loss) attributable to Bio-Techne |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-11.95M | USD | 1 Quarter |
| Other comprehensive income (loss) attributable to Bio-Techne |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-16.61M | USD | 1 Quarter |
| Comprehensive income attributable to Bio-Techne |
ComprehensiveIncomeNetOfTax
|
$72.94M | USD | 1 Quarter |
| Comprehensive income attributable to Bio-Techne |
ComprehensiveIncomeNetOfTax
|
$39.04M | USD | 1 Quarter |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.57 | USD | 1 Quarter |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.32 | USD | 1 Quarter |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.31 | USD | 1 Quarter |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.55 | USD | 1 Quarter |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
156.93M | shares | 1 Quarter |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
158.13M | shares | 1 Quarter |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
162.17M | shares | 1 Quarter |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
161.94M | shares | 1 Quarter |
Cash Flow Statement
79 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net earnings, including noncontrolling interest |
ProfitLoss
|
$89.73M | USD | 1 Quarter |
| Net earnings, including noncontrolling interest |
ProfitLoss
|
$50.99M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$28.54M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$26.64M | USD | 1 Quarter |
| Costs recognized on sale of acquired inventory |
FairValueWriteUpOfAcquiredInventory
|
$300.00K | USD | 1 Quarter |
| Costs recognized on sale of acquired inventory |
FairValueWriteUpOfAcquiredInventory
|
$181.00K | USD | 1 Quarter |
| Deferred income taxes |
DeferredIncomeTaxesAndTaxCredits
|
$-4.77M | USD | 1 Quarter |
| Deferred income taxes |
DeferredIncomeTaxesAndTaxCredits
|
$-11.59M | USD | 1 Quarter |
| Stock-based compensation expense |
ShareBasedCompensation
|
$10.09M | USD | 1 Quarter |
| Stock-based compensation expense |
ShareBasedCompensation
|
$14.46M | USD | 1 Quarter |
| Fair value adjustment to contingent consideration payable |
FairValueAdjustmentToContingentConsiderationPayable
|
$-100.00K | USD | 1 Quarter |
| Fair value adjustment to contingent consideration payable |
FairValueAdjustmentToContingentConsiderationPayable
|
$-1.75M | USD | 1 Quarter |
| Gain on sale of CCXI investment |
GainOnSaleOfInvestments
|
$37.18M | USD | 1 Quarter |
| Fair value adjustment on available-for-sale investments |
FairValueAdjustmentOnAvailableForSaleSecurities
|
$-911.00K | USD | 1 Quarter |
| Fair value adjustment on available-for-sale investments |
FairValueAdjustmentOnAvailableForSaleSecurities
|
$-283.00K | USD | 1 Quarter |
| (Gain) loss on equity method investment |
EquityMethodInvestmentDividendsOrDistributions
|
- | USD | 1 Quarter |
| (Gain) loss on equity method investment |
EquityMethodInvestmentDividendsOrDistributions
|
$2.38M | USD | 1 Quarter |
| Gain on sale of Eminence |
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
|
- | USD | 1 Quarter |
| Gain on sale of Eminence |
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
|
$11.68M | USD | 1 Quarter |
| Leases, net |
NoncashPortionOfLeaseExpense
|
$2.54M | USD | 1 Quarter |
| Leases, net |
NoncashPortionOfLeaseExpense
|
$613.00K | USD | 1 Quarter |
| Other operating activity |
OtherOperatingActivitiesCashFlowStatement
|
$182.00K | USD | 1 Quarter |
| Other operating activity |
OtherOperatingActivitiesCashFlowStatement
|
$-32.00K | USD | 1 Quarter |
| Trade accounts and other receivables, net |
IncreaseDecreaseInAccountsAndOtherReceivables
|
$-17.34M | USD | 1 Quarter |
| Trade accounts and other receivables, net |
IncreaseDecreaseInAccountsAndOtherReceivables
|
$-15.60M | USD | 1 Quarter |
| Inventories |
IncreaseDecreaseInInventories
|
$10.69M | USD | 1 Quarter |
| Inventories |
IncreaseDecreaseInInventories
|
$5.22M | USD | 1 Quarter |
| Prepaid expenses |
IncreaseDecreaseInPrepaidExpense
|
$2.57M | USD | 1 Quarter |
| Prepaid expenses |
IncreaseDecreaseInPrepaidExpense
|
$2.76M | USD | 1 Quarter |
| Trade accounts payable, accrued expenses, contract liabilities, and other |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-2.69M | USD | 1 Quarter |
| Trade accounts payable, accrued expenses, contract liabilities, and other |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-1.40M | USD | 1 Quarter |
| Salaries, wages and related accruals |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$-2.16M | USD | 1 Quarter |
| Salaries, wages and related accruals |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$-28.36M | USD | 1 Quarter |
| Income taxes payable |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$-22.94M | USD | 1 Quarter |
| Income taxes payable |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$2.94M | USD | 1 Quarter |
| Net cash provided by (used in) operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$56.08M | USD | 1 Quarter |
| Net cash provided by (used in) operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$59.38M | USD | 1 Quarter |
| Proceeds from sale of available-for-sale investments |
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
$23.76M | USD | 1 Quarter |
| Proceeds from sale of available-for-sale investments |
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
$14.51M | USD | 1 Quarter |
| Purchases of available-for-sale investments |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$14.50M | USD | 1 Quarter |
| Proceeds from sale of CCXI investment |
ProceedsFromSaleOfEquitySecuritiesFvNi
|
$73.22M | USD | 1 Quarter |
| Additions to property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$9.56M | USD | 1 Quarter |
| Additions to property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$13.59M | USD | 1 Quarter |
| Acquisitions, net of cash acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$166.43M | USD | 1 Quarter |
| Acquisitions, net of cash acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$101.18M | USD | 1 Quarter |
| Distributions from (Investments in) Wilson Wolf |
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
|
$2.15M | USD | 1 Quarter |
| Proceeds from sale of Eminence |
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
|
$17.82M | USD | 1 Quarter |
| Net cash provided by (used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-154.11M | USD | 1 Quarter |
| Net cash provided by (used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-19.69M | USD | 1 Quarter |
| Cash dividends |
PaymentsOfDividendsCommonStock
|
$12.54M | USD | 1 Quarter |
| Cash dividends |
PaymentsOfDividendsCommonStock
|
$12.65M | USD | 1 Quarter |
| Proceeds from stock option exercises |
ProceedsFromStockOptionsExercised
|
$14.39M | USD | 1 Quarter |
| Proceeds from stock option exercises |
ProceedsFromStockOptionsExercised
|
$11.95M | USD | 1 Quarter |
| Re-purchases of common stock |
PaymentsForRepurchaseOfCommonStock
|
$19.56M | USD | 1 Quarter |
| Borrowings under line-of-credit agreement |
ProceedsFromLongTermLinesOfCredit
|
$449.66M | USD | 1 Quarter |
| Borrowings under line-of-credit agreement |
ProceedsFromLongTermLinesOfCredit
|
$160.00M | USD | 1 Quarter |
| Repayments of long-term debt |
RepaymentsOfLinesOfCredit
|
$441.00M | USD | 1 Quarter |
| Repayments of long-term debt |
RepaymentsOfLinesOfCredit
|
$70.00M | USD | 1 Quarter |
| Taxes paid on RSUs and net share settlements |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$20.23M | USD | 1 Quarter |
| Taxes paid on RSUs and net share settlements |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$17.85M | USD | 1 Quarter |
| Other financing activity |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-2.46M | USD | 1 Quarter |
| Net cash provided by (used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-31.81M | USD | 1 Quarter |
| Net cash provided by (used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$71.51M | USD | 1 Quarter |
| Effect of exchange rate changes on cash and cash equivalents |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$-8.69M | USD | 1 Quarter |
| Effect of exchange rate changes on cash and cash equivalents |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$-11.90M | USD | 1 Quarter |
| Net change in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-7.31M | USD | 1 Quarter |
| Net change in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-31.91M | USD | 1 Quarter |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$165.26M | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$180.57M | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$148.66M | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$172.57M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$165.26M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$180.57M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$148.66M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$172.57M | USD | Point-in-time |
| Cash paid for income taxes |
IncomeTaxesPaid
|
$32.80M | USD | 1 Quarter |
| Cash paid for income taxes |
IncomeTaxesPaid
|
$14.89M | USD | 1 Quarter |
| Cash paid for interest |
InterestPaidNet
|
$4.51M | USD | 1 Quarter |
| Cash paid for interest |
InterestPaidNet
|
$3.41M | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.